期刊文献+

阿托伐他汀联合依那普利对高血压合并左心室肥厚患者心电图的逆转作用 被引量:4

The Reversing Effect of Enalapril Combination of Atrovastatin on Electrocardiogram in Patients with High Blood Pressure and Left Ventricular Hypertrophy
下载PDF
导出
摘要 目的探讨阿托伐他汀联合依那普利治疗高血压合并左心肥厚患者的效果及对异常心电图的逆转作用。方法选择2010年1月至2011年1月间我院收治的高血压合并左心室肥厚的患者58例,随机分为观察组和对照组各29例;对照组给予依那普利治疗,观察组在此基础上给予阿托伐他汀治疗;随访半年,观察两组的血压,左室重量指数的改变及心电图QT离散度的变化。结果两组治疗后血压水平分别较治疗前显著降低(P<0.05),但两组间的差别并无显著性(P>0.05);观察组半年后左室重量指数,QT间期离散(QTd)度均小于对照组(P<0.05),且均较较治疗前显著降低(P<0.05)。结论阿托伐他汀联合依那普利治疗高血压合并左心肥厚患者降压效果明显,并能一定程度的逆转左心肥厚和异常心电图。 Objective To study the reversing effect of enalapril combination of atrovastatin on electrocardiogram in patients with high blood pressure and left ventricular hypertrophy. Method 58 cases of patients with high blood pressure and left vertricular hypertrophy were randomly divided into observation group and matched group equally. The matched group took enalapril and the other group took both enalapril and atrovastatin for 6 months. Then observed the alteration of blood pressure, left ventricular weight index and electrocardiogram QT discrete degrees. Result The blood pressure after the treatment were lower, but there is no significant differences between two groups(P)〉0.05). In observation group, left ventricular weight index and electrocardiogram QT discrete degrees were significant lower than before(P〈0.05). Conclusion Enalapril combination of atrovastatin can bring a better reversing effect on electrocardiogram in patients with high blood pressure and left ventricular hypertrophy.
作者 吴锦珍
出处 《中国医药指南》 2011年第36期277-279,共3页 Guide of China Medicine
关键词 高血压 左心肥厚 阿托伐他汀 依那普利 QT间期离散度 Hypertension Ventricular hypertrophy Enalapril Atrovastatin Electrocardiogram QT discrete degrees
  • 相关文献

参考文献3

二级参考文献6

共引文献136

同被引文献32

  • 1徐敏,曹俊娜.阿托伐他汀钙辅助治疗老年高血压50例疗效观察[J].中国老年保健医学,2003,1(3):50-51. 被引量:2
  • 2王志,赵利华,华芳,姜亚秋.冠状动脉病变对QT间期离散度的影响[J].吉林大学学报(医学版),2006,32(5):895-897. 被引量:1
  • 3Pittenger B, Gill EA, Holcslaw TL, et al.Relation of dose of carvedilol to reduction in QT dispersion in patients with mild to moderate heart failure secondary to ischemic or to idiopathic dilated cardiomyopathy.Am J Cardiol, 2004, 94(11):1459-1462.
  • 4王亚丽,官功昌,寿锡凌.稳心颗粒对冠心病室性早搏患者QT间期离散度的影响.陕西中医,2008,29(10):1278-1279.
  • 5赵茂林,项小菊,罗素红.阿托伐他汀联合依那普利治疗单纯收缩期高血压临床观察[J].医学理论与实践,2007,20(12):1406-1407. 被引量:1
  • 6陆再英;钟南山.内科学[M]{H}北京:人民卫生出版社,2008251-256.
  • 7Salvi E,Kutalik Z,Glorioso N,et al.Genomewide association study using a high-density single nucleotide polymorphism array and case-control design identifies a novel essential hypertension susceptibility locus in the promoter region of endothelial NO synthase[J].Hypertension,2012,59(2):248-255.
  • 8Karaman M,Balta S,Seyit Ahmet AY,et al.The comparative effects of valsartan and amlodipine on v Wf levels and N/L ratio in patients with newly diagnosed hypertension[J].Clin Exp Hypertens,2013,35(7):516-522.
  • 9Kojima M,Ohashi M,Dohi Y,et al.Titration of telmisartan,but not addition of amlodipine,reduces urine albumin in diabetic patients treated with telmisartandiuretic[J].J Hypertens,2013,31(1):186-191.
  • 10Kjeldsen SE,Messerli FH,Chiang CE,et al.Are fixed-dose combination antihypertensives suitable as first-line therapy?[J].Curr Med Res Opin,2012,28(10):1685-1697.

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部